問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2026-04-01

蘇育嬅
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2025-12-11 - 2031-06-30

Phase III

Not yet recruiting
A phase 3, randomized, double-blind, placebo-controlled trial was conducted to evaluate the efficacy and safety of GB-0895 adjunctive therapy in adults and adolescents with severe, poorly controlled asthma.
  • Condition/Disease

    Adults and adolescents with severely uncontrolled asthma

  • Test Drug

    GB-0895

Participate Sites
6Sites

Recruiting6Sites